EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

YouTube 바른내시경연구소


[SmallTODAY 034 - Olmesartan-associated sprue-like enteropathy]

Previous | Next


Olmesartan is an angiotensin receptor blocker (ARB) approved for the treatment of hypertension in 2002. FDA reported olmesartan associated sprue-like enteropathy via a MedWatch alert in July 2013 after a case series of 22 patients was reported by Mayo Clinic. The patients usually present with chronic diarrhea, vomiting, abdominal pain, bloating, and a median of a 40 pound weight loss. Dehydration and acute renal failure have also been reported.

자료 제공: 이선영 교수님


[References]

1) EsoTODAY - 십이지장질환 증례토의

2) SmallTODAY - 소장질환 증례토의

3) ColonTODAY - 대장질환 증례토의

4) Dr. Sinn's LiverTODAY - 간질환 증례토의

© 일원내시경교실 바른내시경연구소 이준행. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (2021-4-28)